Navigation Links
Bayer and Onyx Announce Nexavar Data Presentations at 60th American Association for the Study of Liver Diseases Annual Meeting
Date:10/29/2009

ducts industry, Bayer HealthCare combines the global activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. In the U.S., Bayer HealthCare Pharmaceuticals comprises the following business units: Women's Healthcare, Diagnostic Imaging, Specialized Therapeutics, Hematology/Cardiology and Oncology. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar® (sorafenib) tablets, a small molecule drug. For more information about Onyx, visit the company's website at www.onyx-pharm.com.

Forward Looking Statements

This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer Web site at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

This news release also contains "forward-looking statements" of Onyx within the meaning of the federal securities laws. These forward-looking statements include without limitation, statements regarding timing, progress and results of the clinical development, safety, regulatory processes, commercialization efforts or commercial potential of Nexavar. These statemen
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Bayers Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients
2. Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO-ESMO Congress 2009
3. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
4. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
5. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
6. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
7. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
8. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
9. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
10. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
11. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), ... repair and regeneration, today announced that J.J. Finkelstein ... present a corporate overview at two upcoming investor conferences. ... SeeThruEquity 4 th Annual Microcap Conference on Thursday ... at 11:00 am EDT.  A webcast will ...
(Date:5/22/2015)... May 22, 2015 According to ... by Product (Consumables, Instruments, Services), by Test Type (Indirect, ... Flow Cytometry), by End Users - Global Forecast to ... is expected to reach $736.85 Million by 2020 from ... 10.25%. Browse 71 market data Tables ...
(Date:5/22/2015)... May 22, 2015  In a sweeping analysis assessing ... T1D Exchange researchers conclude that there remains ... diabetes across all age groups, but especially for adolescents ... picture of diabetes treatment, underscoring the need to address ... that can help type 1 patients achieve optimal metabolic ...
Breaking Medicine Technology:RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5
... June 14 REO, a leading manufacturer ... Mark Notarfrancesco to the newly created position of ... will direct all aspects of the company,s optics fabrication, ... joining REO, Mark served with Intel Corporation developing and ...
... MARLTON, N.J. , June 14 While Father,s Day ... might give your father or spouse is help and support during the difficult ... , , ... needless distress and side effects, says Michael Diefenbach , Ph.D., associate professor ...
Cached Medicine Technology:Mark Notarfrancesco Joins REO as VP Manufacturing Operations 2Prostate Cancer: The Father's Day Gift You Never Thought About 2
(Date:5/26/2015)... Ontario, CA (PRWEB) May 26, 2015 ... hand protection since 1997, is excited to announce the ... the first medical grade gloves made of polyethylene (PE) ... diagnosis, examination and general applications. , The ... used in making sandwiches or mixing salads but our ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 On June ... a complimentary live online broadcast at 6:00pm PST/9:00 pm ... and Trivedi Master™ Alice Branton welcomes the public to ... a night of profound knowledge, transformation and enlightenment. ... Effect® and no previous knowledge, experience or other prerequisites ...
(Date:5/26/2015)... EMIGSVILLE, PA (PRWEB) May 26, 2015 ... oXygen® XML Editor with the Vasont® CCMS to ... process. Vasont Systems, a top component content management ... Universal Integrator (VUI) extension supports oXygen XML Editor ... , The Vasont Universal Integrator extension merges key ...
(Date:5/26/2015)... 26, 2015 General Networks Corporation ... Corporation. The alliance ensures joint customers will benefit ... General Networks’ expertise in building enterprise content and ... will help customers integrate, manage and operationalize their ... processes. , “Our customers are seeking tools to ...
(Date:5/26/2015)... Foot and Ankle Specialists of ... Leone (Pasadena and Baltimore Divisions) was recently presented ... Medical Association (MPMA) President from 2013 to 2015 at ... Doctorate in Podiatric Medicine from Temple University in 1999 ... in Voorhees, New Jersey. Dr. Leone is an ...
Breaking Medicine News(10 mins):Health News:Enov8® Exam Glove by Adenna® Approved by U.S. FDA 2Health News:The Human Wellness Company Trivedi Master Wellness™ Opens a Complimentary Transformational Community Call to the Public on June 4, 2015 2Health News:The Human Wellness Company Trivedi Master Wellness™ Opens a Complimentary Transformational Community Call to the Public on June 4, 2015 3Health News:Vasont Systems Certifies the Integration between the Vasont® Component Content Management System and oXygen® XML Editor 17.0 2Health News:General Networks Corporation Announces Alliance with MarkLogic 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Podiatrist Receives MPMA Service Award 2
... , FRIDAY, Sept. 9 (HealthDay News) -- College ... power over time, but smaller improvements in speed and ... physical capabilities of 289 Division III college players throughout ... senior year, the players, body mass increased an average ...
... News) -- More than one-half of all adverse drug ... according to a new study. In addition, prior ... which include drug overdoses and internal bleeding associated with ... are life-threatening, said the Swedish researchers. This widespread problem, ...
... , FRIDAY, Sept. 9 (HealthDay News) -- Fundraising methods such ... the ability to make a donation on state income tax ... and prevention programs in the United States, a new study ... enable taxpayers to check a box on their income tax ...
... Coukell, a pharmacist and director of medical programs at ... Health Education Labor and Pensions Committee about the need ... U.S. drug supply. Nearly 80 percent ... Increasingly, Americans rely on pharmaceuticals that are produced ...
... By Jenifer Goodwin HealthDay Reporter , THURSDAY, Sept. ... anxious about caring for their infant. But sometimes that concern ... go wrong. Experts call that condition postpartum obsessive compulsive ... prevent their fears from coming true, such as endlessly washing ...
... (HealthDay News) -- People are at much higher risk ... according to a new study. Canadian researchers found ... is likely to develop COPD, which they called "one of ... emphysema and chronic bronchitis, and the overall risk for developing ...
Cached Medicine News:Health News:Over Half of Adverse Drug Reactions in Hospitals Are Preventable: Study 2Health News:When Protecting Baby Becomes an Obsession 2Health News:When Protecting Baby Becomes an Obsession 3Health News:Risk for COPD Higher Than Thought: Study 2
We offer small and large pre-gelled Surface Electrodes suitable for EMG or EGG recordings....
We offer small and large pre-gelled Surface Electrodes suitable for EGG or EMG recordings. Surface Electrodes, Skin Preparation and Conductive Cream complete the setup for a EGG study and are essenti...
Sandhill Scientific offers a comprehensive selection of solid state and water perfused catheters for both adult & pediatric applications.Contact Sandhill Scientific for full details...
Each solid state catheter kit below is supplied with adapter cable(s) for Polygraf ID and a Manometric Calibrator....
Medicine Products: